GL-ONC3

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGL-ONC3
Drug Alias NameGL-ONC3
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCell death stimulantsAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenelux Corporation
China Registration ClassN/A

Develop Information

Active CompaniesGenelux Corporation
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A